|
| |
Articles
1-100 out of 100 article(s)
| Title |
Author |
Type |
Date |
Words |
| Human Genome Sciences Announces Pricing of Public Offering of Common Stock. |
|
|
Dec 3, 2009 |
618 |
| BIOCUREX SHAREHOLDERS INCREASE CAPITALIZATION AND CHANGE NAME. |
|
|
Dec 1, 2009 |
479 |
| Human Genome Sciences Announces Proposed Public Offering of Common Stock. |
|
|
Nov 30, 2009 |
701 |
| United States: Calix plans $100 million IPO. |
|
|
Nov 25, 2009 |
351 |
| Russia : Stem Cell Institute Prepares for IPO. |
|
Company overview |
Nov 17, 2009 |
522 |
| Investors learn of the new normal for biotech: more companies are focusing on projects that might pay off in the short term. |
Chambers, Heather |
|
Nov 2, 2009 |
704 |
| Zacks Sell List Highlights: Pinnacle Financial Partners, Marten Transport Ltd., Genzyme Corporation and MDS Inc. |
|
|
Oct 23, 2009 |
986 |
| Biotechs weigh options as IPO market hints at rebound: virtual, low-overhead business model offers promise for firms. |
Chambers, Heather |
|
Oct 19, 2009 |
652 |
| NASDAQ sees momentum in IPOs. |
|
|
Oct 8, 2009 |
250 |
| United States : Keryx expects $20 million from stock offering. |
|
|
Sep 29, 2009 |
159 |
| Talecris Commences Initial Public Offering of Common Stock. |
|
|
Sep 15, 2009 |
486 |
| Disappointing clinical trial pummels Acadia: data suggests drug could have other applications. |
Chambers, Heather |
|
Sep 14, 2009 |
672 |
| Acadia shares slump on clinical trial results. |
Chambers, Heather |
Brief article |
Sep 7, 2009 |
129 |
| Illumina. |
Allen, Mike |
Brief article |
Aug 31, 2009 |
36 |
| Israeli Firm Reports Success for Swine Flu Vaccine. |
|
|
Aug 25, 2009 |
84 |
| Seattle Genetics Announces Pricing of Public Offering of Common Stock. |
|
|
Aug 11, 2009 |
596 |
| Seattle Genetics Announces Proposed Public Offering of Common Stock. |
|
|
Aug 10, 2009 |
509 |
| Fitch Affirms Life Technologies at 'BBB-'; Outlook Stable. |
|
|
Aug 4, 2009 |
660 |
| Acadia Pharmaceuticals. |
Chambers, Heather |
Brief article |
Aug 3, 2009 |
174 |
| Intellikine raises $51m in quest for cancer drug. |
Chambers, Heather |
Brief article |
Jul 13, 2009 |
182 |
| Trimeris Discloses Tax Classification of 2008 Dividends. |
|
|
Mar 23, 2009 |
216 |
| United States: Roche s $16 Billion Bond Sale Shows Demand for Debt. |
|
|
Feb 19, 2009 |
163 |
| Seattle Genetics Announces Pricing of Common Stock Offering. |
|
|
Jan 28, 2009 |
314 |
| Australia : Progen Pharmaceuticals and Avexa agree to merge. |
|
|
Dec 24, 2008 |
348 |
| Progen Pharmaceuticals Limited and Avexa Limited Agree to Merge. |
|
|
Dec 21, 2008 |
1391 |
| Orexigen shares swoon. |
Chambers, Heather |
Brief article |
Dec 15, 2008 |
220 |
| Cellectis Meets the 20 Meganucleases Annual Capacity Milestone. |
|
|
Dec 12, 2008 |
713 |
| Trimeris Announces Special Dividend. |
|
|
Dec 9, 2008 |
195 |
| Healthnostics Approves Reverse Stock Split. |
|
|
Nov 21, 2008 |
286 |
| Medical startups to pursue injection of funding: life science businesses to seek line on capital at SoCalBio event. |
Crowe, Deborah |
|
Sep 15, 2008 |
564 |
| Illumina Announces 2-for-1 Stock Split. |
|
|
Sep 10, 2008 |
389 |
| Fitch Publishes Special Report on Invitrogen Corp. |
|
|
Sep 8, 2008 |
249 |
| Neurocrine shares edge up after promising drug tests. |
Chambers, Heather |
Brief article |
Sep 8, 2008 |
268 |
| Illumina Announces Completion of Public Offering of Common Stock. |
|
|
Aug 12, 2008 |
103 |
| Illumina makes $300m stock move: genetic analysis company Illumina Inc. said it will offer 3.5 million shares of its stock to the public for $87.50 a share. |
Chambes, Heather |
Brief article |
Aug 11, 2008 |
125 |
| Illumina Announces Pricing of its Public Offering of Common Stock. |
|
|
Aug 7, 2008 |
196 |
| Fitch Rates Invitrogen Corp. 'BBB-'; Outlook Stable. |
|
|
Aug 4, 2008 |
453 |
| Illumina Reports Financial Results for Second Quarter 2008. |
|
Financial report |
Jul 22, 2008 |
2055 |
| San Diego public stocks. |
|
Statistical table |
Jul 7, 2008 |
3805 |
| Sequenom to offer 5.5 million shares. |
Graves, Brad |
Brief article |
Jun 30, 2008 |
68 |
| Sequenom Announces Pricing of Public Offering of Common Stock. |
|
|
Jun 26, 2008 |
508 |
| Sequenom Launches Public Offering of Common Stock. |
|
|
Jun 23, 2008 |
486 |
| Invitrogen Announces Two-for-One Stock Split. |
|
|
Apr 30, 2008 |
369 |
| VioQuest Pharmaceuticals Announces New Trading Symbol. |
|
|
Apr 29, 2008 |
207 |
| United States: 3SBio to buy back up to $20M of ADS. |
|
|
Mar 20, 2008 |
115 |
| Q-Med: The Proposal of the Board Regarding Dividend. |
|
|
Mar 14, 2008 |
298 |
| Orexigen Therapeutics Inc. |
Allen, Mike |
Brief article |
Feb 25, 2008 |
57 |
| Invitrogen Corp. |
Allen, Mike |
Brief article |
Feb 25, 2008 |
43 |
| Seattle Genetics Announces Completion of Common Stock Offering, Including Exercise of Over-Allotment Option. |
|
|
Jan 24, 2008 |
432 |
| Illumina bolsters portfolio with Bovine detection product. |
Chambers, Heather |
Brief article |
Jan 21, 2008 |
187 |
| Seattle Genetics Announces Pricing of Public Offering of Common Stock. |
|
|
Jan 18, 2008 |
519 |
| Business journal's public stock index declines modest 3 percent in 2007: five largest companies all show big gains. |
Allen, Mike |
|
Jan 14, 2008 |
1209 |
| Seattle Genetics Announces Proposed Public Offering of Common Stock. |
|
|
Jan 14, 2008 |
446 |
| Nanogen Inc. |
Allen, Mike |
Brief article |
Dec 10, 2007 |
55 |
| Senomyx shares fall on Kraft collaboration pull-out. |
Chambers, Heather |
Brief article |
Nov 12, 2007 |
242 |
| Pluristem Announces a Reverse Stock Split in Conjunction With Its Application for Listing on the NASDAQ Capital Market. |
|
|
Nov 8, 2007 |
602 |
| Nanosphere Announces Exercise of Over-Allotment Option and Closing of Initial Public Offering. |
|
|
Nov 6, 2007 |
296 |
| IPO has star power. |
Graves, Brad |
|
Nov 5, 2007 |
120 |
| Corporate Finance Leader Joins Board of Exagen Diagnostics, Inc(TM). |
|
|
Nov 1, 2007 |
444 |
| Avantium to go public. |
|
Brief article |
Oct 31, 2007 |
100 |
| Nanobac Pharmaceuticals Board of Directors Approves Interim Financing and Stock Buy Back. |
|
|
Sep 27, 2007 |
441 |
| Employee Share Incentives In Recent Biotech IPOs. |
|
Survey |
Aug 2, 2007 |
1398 |
| Local companies finally shake the fear of going public. |
Fine, Howard |
|
Jul 16, 2007 |
1212 |
| Mergers, acquisitions leading 'exit strategy' for biotech companies: investors: initial public offerings not always best way to cash out. |
Weeks, Katie |
|
Jul 16, 2007 |
916 |
| Clinical Data Announces Public Offering of Common Stock. |
|
|
Jul 10, 2007 |
745 |
| Low trading volume results in Cytori delisting. |
Weeks, Katie |
Brief article |
Jul 2, 2007 |
79 |
| ArQule Announces Completion of Common Stock Offering. |
|
|
Jun 19, 2007 |
497 |
| ArQule Announces Offering of Common Stock. |
|
|
Jun 14, 2007 |
501 |
| Response Genetics IPO. |
Crowe, Deborah |
|
Jun 11, 2007 |
139 |
| ArQule Announces Offering of Common Stock. |
|
|
Jun 6, 2007 |
483 |
| Response Genetics, Inc. (RGDX) Announces Pricing of Its Initial Public Offering. |
|
|
Jun 5, 2007 |
468 |
| Deltagen Reports Full-Year 2006 Consolidated Financial Results and Declares a 5-Cent Per Share Dividend. |
|
|
May 10, 2007 |
1326 |
| PolyMedix, Inc. Announces Filing of Registration Statement in Connection with a Common Stock and Warrant Offering of up to $35 Million. |
|
|
May 9, 2007 |
590 |
| Halozyme gets HALO. |
Weeks, Katie |
Brief article |
May 7, 2007 |
98 |
| ACADIA Pharmaceuticals Announces Pricing of Public Stock Offering. |
|
|
Apr 4, 2007 |
357 |
| ACADIA Pharmaceuticals Announces Proposed Public Stock Offering. |
|
|
Apr 2, 2007 |
313 |
| Fitch Rates Eli Lilly & Co.'s $2.5B Senior Notes 'AA'. |
|
|
Mar 8, 2007 |
377 |
| Favrille to raise $10M in stock offering. |
Killion, Andy |
|
Feb 19, 2007 |
95 |
| Subsidiary for sale. |
Graves, Brad |
Brief article |
Feb 19, 2007 |
80 |
| Weekly top losers. |
|
Statistical table |
Jan 22, 2007 |
200 |
| Weekly top gainers. |
|
Brief article |
Jan 15, 2007 |
207 |
| Weekly top gainers. |
|
Brief article |
Jan 1, 2007 |
200 |
| Deltagen Reports 2006 Third Quarter Financial Results and Declares Year-End Dividend. |
|
|
Dec 8, 2006 |
1277 |
| Fitch Affirms Eli Lilly & Co.'s Ratings; Outlook Stable. |
|
|
Oct 18, 2006 |
274 |
| Zacks Sell List Highlights: Bally Technologies, Polaris, Millennium Pharmaceuticals and Compuware. |
|
|
Oct 18, 2006 |
937 |
| Zacks Sell List Highlights: Landry's, Lithia Motors, Affymetrix Inc and Celgene. |
|
|
Oct 17, 2006 |
925 |
| Venture capitalists fuel Altra's ethanol development drive. |
Cox, Dan |
|
Oct 9, 2006 |
452 |
| Business Briefs. |
|
|
Oct 3, 2006 |
393 |
| Zacks Sell List Highlights: Applebee's, Invitrogen, Lamar and Novartis. |
|
|
Sep 26, 2006 |
948 |
| Weekly top gainers. |
|
Brief article |
Sep 25, 2006 |
200 |
| Caprion Pharmaceuticals Withdraws Initial Public Offering. |
|
|
Jul 27, 2006 |
244 |
| Simulations Plus Updates July 20 Stock Split Announcement. |
|
|
Jul 25, 2006 |
136 |
| Neurocrine rallies. |
Weeks, Katie |
Brief article |
Jun 19, 2006 |
161 |
| Nanogen Inc. |
Allen, Mike |
Brief article |
May 22, 2006 |
35 |
| Fitch Rates Montgomery County, Maryland's $100MM GOs 'AAA'. |
|
|
May 2, 2006 |
500 |
| Business Briefs. |
|
|
Apr 18, 2006 |
397 |
| Local biotech company goes public with reverse merger. |
Crowe, Deborah |
|
Apr 17, 2006 |
408 |
| SFBC International Comments on Moody's Debt Ratings Action. |
|
|
Apr 12, 2006 |
724 |
| Sequenom gets $30 million promise. |
Allen, Mike |
Brief article |
Apr 3, 2006 |
174 |
| Concentrated announcements on clustered data: an event study on biotechnology stocks. |
Bastin, Veronique; Hubner, Georges |
|
Mar 22, 2006 |
13663 |
|
